We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$2B
AUM Growth
+$57.2M
Cap. Flow
-$399M
Cap. Flow %
-19.96%
Top 10 Hldgs %
47.37%
Holding
111
New
26
Increased
11
Reduced
29
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 22.25%
2 Consumer Discretionary 9.14%
3 Real Estate 4.22%
4 Energy 2.62%
5 Financials 2.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COF icon
26
Capital One
COF
$124B
$15.4M 0.77%
186,765
-305,200
-62% -$24.8M
ASPS icon
27
Altisource Portfolio Solutions
ASPS
$65.4M
$15.2M 0.76%
56,355
+17,086
+44% +$8.83M
TVTX icon
28
Travere Therapeutics
TVTX
$5.33B
$15.2M 0.76%
1,267,710
-1,054,747
-45% -$10.9M
BCRX icon
29
BioCryst Pharmaceuticals
BCRX
$2.37B
$15.2M 0.76%
1,246,282
+520,548
+72% +$5.75M
BLUE
30
DELISTED
bluebird bio
BLUE
$14.9M 0.75%
12,568
-15,734
-56% -$10.5M
CYTR
31
DELISTED
CytRx Corp
CYTR
$14.1M 0.7%
857,261
+118,694
+16% +$1.85M
FPRX
32
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$13.5M 0.67%
498,392
-147,313
-23% -$2.54M
ASPS icon
33
PUT
Altisource Portfolio Solutions
ASPS
$65.4M
$13M 0.65%
48,163
+14,413
+43% +$7.45M
AWI icon
34
CALL
Armstrong World Industries
AWI
$6.86B
$12.8M 0.64%
+250,000
New +$12.4M
ANAC
35
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$12.1M 0.6%
373,953
-246,850
-40% -$7.41M
DYAX
36
DELISTED
DYAX CORPORATION
DYAX
$11.4M 0.57%
813,666
-842,634
-51% -$10.5M
THS
37
DELISTED
Treehouse Foods
THS
$11.3M 0.57%
132,450
NXEO
38
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$10.3M 0.51%
1,000,000
ARMH
39
PUT
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$10.2M 0.51%
220,100
HLSS
40
PUT
DELISTED
HOME LN SERVICING SOLUTIONS LTD(CAYMAN ISLANDS)
HLSS
$9.92M 0.5%
+508,000
New +$10.1M
XNCR icon
41
Xencor
XNCR
$1.44B
$9.84M 0.49%
651,444
-108,556
-14% -$1.26M
CASC
42
DELISTED
Cascadian Therapeutics, Inc.
CASC
$9.48M 0.47%
840,747
-276,931
-25% -$3.01M
RESI
43
PUT
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$9.31M 0.47%
+480,000
New +$10.2M
BABA icon
44
Alibaba
BABA
$269B
$8.91M 0.45%
85,700
-264,300
-76% -$27.1M
ETFC
45
CALL
DELISTED
E*Trade Financial Corporation
ETFC
$8.85M 0.44%
365,000
MRTX
46
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.58M 0.43%
507,184
NSM
47
PUT
DELISTED
Nationstar Mortgage Holdings
NSM
$8.46M 0.42%
+300,000
New +$9.28M
COF icon
48
CALL
Capital One
COF
$124B
$8.26M 0.41%
+100,000
New +$8.14M
XLE icon
49
CALL
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$7.92M 0.4%
+200,000
New +$8.31M
MDVN
50
DELISTED
MEDIVATION, INC.
MDVN
$7.51M 0.38%
150,856
-16,800
-10% -$873K

Similar funds

QVT Financial's Q4 2014 Portfolio in Review

As of Q4 2014, QVT Financial held 111 positions worth $2B, up 2.9% from $1.94B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

QVT Financial withdrew a net $399M in Q4 2014, closing 16 positions and reducing 29 holdings. Its most notable exit was PEREGRINE SEMICONDUCTOR CORP COM STK (DE), an estimated $40.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Real Estate.

Against the trend, QVT Financial opened a new position in COVIDIEN PLC COM SHS NEW (IRELAND) worth $123M.

  • QVT Financial's largest Q4 2014 buy was COVIDIEN PLC COM SHS NEW (IRELAND): 1,200,000 shares worth $123M.
  • QVT Financial added most to Arrowhead Research in Q4 2014, an estimated $13M increase.
  • QVT Financial's biggest Q4 2014 reduction was YPF, cutting an estimated $29.9M.
  • QVT Financial fully exited PEREGRINE SEMICONDUCTOR CORP COM STK (DE) in Q4 2014, selling an estimated $40.3M.
  • QVT Financial's ten largest holdings make up 47% of its $2B portfolio in Q4 2014.
  • QVT Financial opened 26 new positions and closed 16 in Q4 2014.
  • QVT Financial's portfolio value rose 2.9% quarter-over-quarter to $2B.

Based on QVT Financial's 13F filing for Q4 2014, filed 17 Feb 2015.